Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema
Introduction: Diabetes Mellitus (DM) is a common disease with multiple systemic complications. Diabetic macular oedema is the main threat to vision in patients with diabetic retinopathy, which results from the increased permeability of the inner and outer blood-retinal barrier. Macular argon las...
المؤلفون الرئيسيون: | Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi, Khalil Al Salem |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
JCDR Research and Publications Private Limited
2020-11-01
|
سلاسل: | Journal of Clinical and Diagnostic Research |
الموضوعات: | |
الوصول للمادة أونلاين: | https://jcdr.net/articles/PDF/14179/45742_CE[Ra1]_F(SL)_PF1(AG_KM)_PFA_PB(AG_KM)_PN(SL).pdf |
مواد مشابهة
-
Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
حسب: Kartasasmita A, وآخرون
منشور في: (2019-09-01) -
Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema
حسب: Ahmed H Mohamed
منشور في: (2016-01-01) -
Changes in Macular Oedema by Optical Coherence Tomography in Patients Receiving Intravitreal Bevacizumab: A Retrospective Observational Hospital Based Study
حسب: Ajit K Joshi, وآخرون
منشور في: (2020-06-01) -
Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
حسب: Gopal K Das, وآخرون
منشور في: (2018-01-01) -
Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
حسب: Wei Zhang, وآخرون
منشور في: (2021-04-01)